Skip to main content

Ethyol Disease Interactions

There are 3 disease interactions with Ethyol (amifostine).

Major

Amifostine (applies to Ethyol) dehydration

Major Potential Hazard, High plausibility.

Patients who are dehydrated should not receive amifostine therapy and appropriate hydration prior to administration of amifostine is necessary. Hypotensive episodes have occurred in 62% of patients receiving amifostine. Amifosine reduces the cumulative renal toxicity associated with cisplatin therapy.

Switch to professional interaction data

Major

Amifostine (applies to Ethyol) hypotension

Major Potential Hazard, Moderate plausibility. Applicable conditions: Ischemic Heart Disease, Cerebral Vascular Disorder, Congestive Heart Failure, Arrhythmias, Dehydration

Patients who are hypotensive or in state of dehydration, or those that are unable to discontinue antihypertensive treatment 24 hours prior to amifostine administration should not receive amifostine. Transient hypotensive episodes have occurred in 62% of patients receiving amifostine. Three percent of patients required discontinuation of amifostine. Therapy with amifostine should be administered cautiously in patients adversely affected by hypotensive effects such as cardiovascular conditions of arrhythmia, angina, or CHF or cerebrovascular conditions of or history of stroke or ischemic attacks. Clinical monitoring of blood pressure is necessary.

Switch to professional interaction data

Moderate

Amifostine (applies to Ethyol) hypocalcemia

Moderate Potential Hazard, Low plausibility.

Hypocalcemic effects during amifostine therapy are rare, but appear to result from inhibition of parathyroid hormone secretion and bone resorption and from increased urinary calcium elimination. Therapy with amifostine should be administered cautiously in patients with or predisposed to hypocalcemia, including hypoparathyroidism.

Switch to professional interaction data

Ethyol drug interactions

There are 123 drug interactions with Ethyol (amifostine).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer